Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(13):989; doi:10.1093/jnci/96.13.989
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

Awards, Appointments, Announcements

The first 10% of the full text of this article appears below.

{blacksquare} The American Society for Clinical Oncology (ASCO) introduced several new changes to its leadership at its annual meeting in June:

David H. Johnson, M.D., deputy director of the Vanderbilt-Ingram Cancer Center in Nashville, Tenn., was named president. Sandra J. Horning, M.D., professor of medicine in the divisions of medical oncology and blood and marrow transplantation at Stanford University, will succeed him as president-elect.

The five new members of the ASCO Board of Directors are: . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?